 |
|
|
| |
EQ-5D Results in Asian Patients with HCV Genotype 1b
Receiving Daclatasvir plus Asunaprevir who are
Interferon Intolerant/Ineligible
|
| |
| |
Reported by Jules Levin
25th Conference of the Asian Pacific Association for the Study of the Liver (APASL 2016). Tokyo, Japan, February 20Ð24, 2016
Gail Wygant,1 Ling Mo,2 Michelle Treitel,1 Rafia Bhore,1 Anne Torbeyns3
1Bristol-Myers Squibb Research and Development, Princeton, USA; 2Bristol-Myers Squibb, Shanghai, China; 3 Bristol-Myers Squibb, Braine-l'Alleud, Belgium
|
| |
|
|
|
|
|
